Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. (January 2023)
- Record Type:
- Journal Article
- Title:
- Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents. (January 2023)
- Main Title:
- Pre-clinical and clinical importance of miR-21 in human cancers: Tumorigenesis, therapy response, delivery approaches and targeting agents
- Authors:
- Hashemi, Mehrdad
Mirdamadi, Motahare Sadat Ayat
Talebi, Yasmin
Khaniabad, Nasrin
Banaei, Gooya
Daneii, Pouria
Gholami, Sadaf
Ghorbani, Amin
Tavakolpournegari, Alireza
Farsani, Zoheir Mohammadian
Zarrabi, Ali
Nabavi, Noushin
Zandieh, Mohammad Arad
Rashidi, Mohsen
Taheriazam, Afshin
Entezari, Maliheh
Khan, Haroon - Abstract:
- Abstract: The field of non-coding RNA (ncRNA) has made significant progress in understanding the pathogenesis of diseases and has broadened our knowledge towards their targeting, especially in cancer therapy. ncRNAs are a large family of RNAs with microRNAs (miRNAs) being one kind of endogenous RNA which lack encoded proteins. By now, miRNAs have been well-coined in pathogenesis and development of cancer. The current review focuses on the role of miR-21 in cancers and its association with tumor progression. miR-21 has both oncogenic and onco-suppressor functions and most of the experiments are in agreement with the tumor-promoting function of this miRNA. miR-21 primarily decreases PTEN expression to induce PI3K/Akt signaling in cancer progression. Overexpression of miR-21 inhibits apoptosis and is vital for inducing pro-survival autophagy. miR-21 is vital for metabolic reprogramming and can induce glycolysis to enhance tumor progression. miR-21 stimulates EMT mechanisms and increases expression of MMP-2 and MMP-9 thereby elevating tumor metastasis. miR-21 is a target of anti-cancer agents such as curcumin and curcumol and its down-regulation impairs tumor progression. Upregulation of miR-21 results in cancer resistance to chemotherapy and radiotherapy. Increasing evidence has revealed the role of miR-21 as a biomarker as it is present in both the serum and exosomes making them beneficial biomarkers for non-invasive diagnosis of cancer. Graphical Abstract: ga1
- Is Part Of:
- Pharmacological research. Volume 187(2023)
- Journal:
- Pharmacological research
- Issue:
- Volume 187(2023)
- Issue Display:
- Volume 187, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 187
- Issue:
- 2023
- Issue Sort Value:
- 2023-0187-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-01
- Subjects:
- MicroRNA -- Non-coding RNA -- LncRNA -- CircRNA -- Drug resistance -- Immune evasion
Pharmacology -- Periodicals
Pharmacology -- Periodicals
Research -- Periodicals
Médicaments -- Recherche -- Périodiques
Pharmacologie -- Périodiques
615.105 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10436618 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.phrs.2022.106568 ↗
- Languages:
- English
- ISSNs:
- 1043-6618
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 6446.550000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 25678.xml